purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
zostavax
merck sharp & dohme b.v. - virusul varicelo-zoster (viu, atenuat) - herpes zoster; immunization - vaccinuri virale - zostavax este indicat pentru prevenirea herpes zoster (zoster sau herpes zoster) și a nevralgiei postherpetice legate de herpes zoster. zostavax este indicat pentru imunizarea persoanelor cu vârsta de 50 ani sau mai în vârstă.
falvax 250 mg
betapharm arzneimittel gmbh - germania - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni
purevax felv
boehringer ingelheim vetmedica gmbh - virusul leucemiei feline canarypox virus recombinat (vcp97) - produsele imunologice pentru felidae, - pisici - imunizarea activă a pisicilor de vârsta de 8 săptămâni sau mai mari împotriva leucemiei feline pentru prevenirea viremiei persistente și a semnelor clinice ale bolilor. debutul imunității a fost demonstrat la 2 săptămâni după vaccinarea primară. durata imunității este de un an de la ultima vaccinare.
purevax rabies
boehringer ingelheim vetmedica gmbh - virus vcp65 - immunologicals - pisici - imunizarea activă a pisicilor cu vârsta de 12 săptămâni și peste pentru a preveni mortalitatea datorată infecției cu rabie. debutul imunității: la 4 săptămâni după vaccinarea primară. durata imunității după vaccinarea primară: 1 an. durata imunității după revaccinare: 3 ani.
purevax rc
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.
purevax rcp
boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.
purevax rcpch
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. incidența imunității a fost demonstrată la o săptămână după vaccinarea primară pentru rinotraheită, calicivirus, chlamydophila felis și componentele panleucopeniei. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcch
merial - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain) - produsele imunologice pentru felidae, - pisici - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs and excretion;against chlamydophila felis infection to reduce clinical signs. incidența imunității a fost demonstrată la o săptămână după vaccinarea primară pentru rinotraheită, calicivirus și componente chlamydophila felis. durata imunității este de 1 an după ultima (re) vaccinare.